NBPF15
gene geneOn this page
Also known as MGC8902
Summary
NBPF15 (NBPF member 15, HGNC:28791) is a protein-coding gene on chromosome 1q21.1, encoding NBPF family member NBPF15 (Q8N660).
This gene is a member of the neuroblastoma breakpoint family (NBPF) which consists of dozens of recently duplicated genes primarily located in segmental duplications on human chromosome 1. This gene family has experienced its greatest expansion within the human lineage and has expanded, to a lesser extent, among primates in general. Members of this gene family are characterized by tandemly repeated copies of DUF1220 protein domains. Gene copy number variations in the human chromosomal region 1q21.1, where most DUF1220 domains are located, have been implicated in a number of developmental and neurogenetic diseases such as microcephaly, macrocephaly, autism, schizophrenia, cognitive disability, congenital heart disease, neuroblastoma, and congenital kidney and urinary tract anomalies. Altered expression of some gene family members is associated with several types of cancer. This gene family contains numerous pseudogenes.
Source: NCBI Gene 284565 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 154 total — 1 pathogenic
- MANE Select transcript:
NM_001385408
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:28791 |
| Approved symbol | NBPF15 |
| Name | NBPF member 15 |
| Location | 1q21.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MGC8902 |
| Ensembl gene | ENSG00000266338 |
| Ensembl biotype | protein_coding |
| OMIM | 610414 |
| Entrez | 284565 |
Gene structure
Transcript identifiers
Ensembl transcripts: 69 — 68 protein_coding, 1 protein_coding_CDS_not_defined
ENST00000478419, ENST00000488031, ENST00000577412, ENST00000579734, ENST00000581897, ENST00000584793, ENST00000614785, ENST00000869020, ENST00000869021, ENST00000869022, ENST00000869023, ENST00000869024, ENST00000869025, ENST00000869026, ENST00000869027, ENST00000869028, ENST00000869029, ENST00000869030, ENST00000869031, ENST00000869032, ENST00000869033, ENST00000869034, ENST00000912883, ENST00000912884, ENST00000912885, ENST00000912886, ENST00000912887, ENST00000912888, ENST00000912889, ENST00000912890, ENST00000912891, ENST00000912892, ENST00000912893, ENST00000912894, ENST00000969975, ENST00000969976, ENST00000969977, ENST00000969978, ENST00000969979, ENST00000969980, ENST00000969981, ENST00000969982, ENST00000969983, ENST00000969984, ENST00000969985, ENST00000969986, ENST00000969987, ENST00000969988, ENST00000969989, ENST00000969990, ENST00000969991, ENST00000969992, ENST00000969993, ENST00000969994, ENST00000969995, ENST00000969996, ENST00000969997, ENST00000969998, ENST00000969999, ENST00000970000, ENST00000970002, ENST00000970003, ENST00000970004, ENST00000970006, ENST00000970008, ENST00000970010, ENST00000970011, ENST00000970013, ENST00000970015
RefSeq mRNA: 54 — MANE Select: NM_001385408
NM_001170755, NM_001385373, NM_001385374, NM_001385375, NM_001385376, NM_001385377, NM_001385378, NM_001385403, NM_001385404, NM_001385405, NM_001385406, NM_001385407, NM_001385408, NM_001385409, NM_001385410, NM_001385411, NM_001385412, NM_001385413, NM_001385414, NM_001385415, NM_001385416, NM_001385417, NM_001385418, NM_001385419, NM_001385420, NM_001385421, NM_001385422, NM_001385423, NM_001385424, NM_001385425, NM_001385426, NM_001385427, NM_001385428, NM_001385429, NM_001385430, NM_001385431, NM_001385432, NM_001385433, NM_001385434, NM_001385435, NM_001385436, NM_001385437, NM_001385438, NM_001385439, NM_001385440, NM_001385441, NM_001385442, NM_001385443, NM_001385444, NM_001385445, NM_001385446, NM_001385447, NM_001385448, NM_173638
CCDS: CCDS72852, CCDS91031
Canonical transcript exons
ENST00000581897 — 22 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002687127 | 144461381 | 144461669 |
| ENSE00002691863 | 144440141 | 144440295 |
| ENSE00002698832 | 144459366 | 144459483 |
| ENSE00002703206 | 144460843 | 144460961 |
| ENSE00002726155 | 144423870 | 144423975 |
| ENSE00003463961 | 144429700 | 144429863 |
| ENSE00003483704 | 144427818 | 144427990 |
| ENSE00003487468 | 144424690 | 144424862 |
| ENSE00003494864 | 144421390 | 144423256 |
| ENSE00003499111 | 144428606 | 144428657 |
| ENSE00003536781 | 144437945 | 144438047 |
| ENSE00003540135 | 144433773 | 144433824 |
| ENSE00003546054 | 144426278 | 144426450 |
| ENSE00003551884 | 144425517 | 144425568 |
| ENSE00003561956 | 144450772 | 144450870 |
| ENSE00003608457 | 144435111 | 144435316 |
| ENSE00003618516 | 144436895 | 144437109 |
| ENSE00003624239 | 144435781 | 144435853 |
| ENSE00003681603 | 144427047 | 144427098 |
| ENSE00003718194 | 144456537 | 144456805 |
| ENSE00003718754 | 144448775 | 144448916 |
| ENSE00003937989 | 144439829 | 144440038 |
Expression profiles
Bgee: expression breadth ubiquitous, 136 present calls, max score 93.98.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.2878 / max 5.0569, expressed in 132 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 14114 | 0.2878 | 132 |
Top tissues by expression
138 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| ventricular zone | UBERON:0003053 | 93.98 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 93.74 | gold quality |
| cerebellar cortex | UBERON:0002129 | 93.73 | gold quality |
| cerebellum | UBERON:0002037 | 93.66 | gold quality |
| thymus | UBERON:0002370 | 93.64 | silver quality |
| right hemisphere of cerebellum | UBERON:0014890 | 93.50 | gold quality |
| stromal cell of endometrium | CL:0002255 | 91.72 | gold quality |
| thyroid gland | UBERON:0002046 | 90.95 | gold quality |
| ganglionic eminence | UBERON:0004023 | 90.86 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 90.71 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 90.68 | gold quality |
| right lobe of liver | UBERON:0001114 | 90.65 | gold quality |
| right lung | UBERON:0002167 | 90.19 | gold quality |
| mucosa of stomach | UBERON:0001199 | 90.04 | gold quality |
| right uterine tube | UBERON:0001302 | 89.86 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 89.75 | gold quality |
| lower esophagus | UBERON:0013473 | 89.74 | gold quality |
| spleen | UBERON:0002106 | 89.70 | gold quality |
| body of pancreas | UBERON:0001150 | 89.58 | gold quality |
| body of uterus | UBERON:0009853 | 89.50 | gold quality |
| cortical plate | UBERON:0005343 | 89.49 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 89.34 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 89.31 | gold quality |
| tibial artery | UBERON:0007610 | 89.27 | gold quality |
| popliteal artery | UBERON:0002250 | 89.25 | gold quality |
| endometrium | UBERON:0001295 | 89.13 | gold quality |
| liver | UBERON:0002107 | 89.09 | gold quality |
| left ovary | UBERON:0002119 | 89.09 | gold quality |
| myometrium | UBERON:0001296 | 88.92 | gold quality |
| lymph node | UBERON:0000029 | 88.86 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 11.25 |
| E-MTAB-5061 | no | 3.08 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): ESR1, ESR2, NR1I2
miRNA regulators (miRDB)
71 targeting NBPF15, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4692 | 100.00 | 67.32 | 2066 |
| HSA-MIR-3646 | 100.00 | 73.56 | 5283 |
| HSA-MIR-4514 | 99.99 | 67.10 | 1870 |
| HSA-MIR-3065-5P | 99.97 | 71.56 | 3281 |
| HSA-MIR-3605-5P | 99.96 | 67.12 | 932 |
| HSA-MIR-141-3P | 99.94 | 72.79 | 2421 |
| HSA-MIR-200A-3P | 99.94 | 72.68 | 2420 |
| HSA-MIR-6499-3P | 99.90 | 66.38 | 1212 |
| HSA-MIR-3529-3P | 99.90 | 73.55 | 3045 |
| HSA-MIR-3671 | 99.90 | 73.04 | 3897 |
| HSA-MIR-124-3P | 99.89 | 73.74 | 3043 |
| HSA-MIR-506-3P | 99.89 | 73.55 | 3057 |
| HSA-MIR-544A | 99.84 | 68.66 | 1965 |
| HSA-MIR-4659A-3P | 99.80 | 72.62 | 4248 |
| HSA-MIR-4659B-3P | 99.80 | 72.62 | 4248 |
| HSA-MIR-4319 | 99.76 | 69.83 | 2586 |
| HSA-MIR-33A-3P | 99.70 | 70.27 | 3362 |
| HSA-MIR-5093 | 99.67 | 69.26 | 2291 |
| HSA-MIR-580-3P | 99.67 | 69.23 | 1841 |
| HSA-MIR-545-5P | 99.66 | 70.18 | 2308 |
| HSA-MIR-10394-5P | 99.65 | 66.83 | 1852 |
| HSA-MIR-1205 | 99.65 | 66.76 | 1826 |
| HSA-MIR-6832-5P | 99.58 | 64.82 | 1132 |
| HSA-MIR-549A-3P | 99.54 | 68.17 | 825 |
| HSA-MIR-7106-5P | 99.53 | 67.47 | 3574 |
| HSA-MIR-1207-5P | 99.49 | 69.11 | 2983 |
| HSA-MIR-3915 | 99.45 | 68.49 | 1905 |
| HSA-MIR-942-5P | 99.41 | 68.40 | 1977 |
| HSA-MIR-125A-5P | 99.36 | 70.59 | 1640 |
| HSA-MIR-125B-5P | 99.36 | 70.36 | 1662 |
Literature-anchored findings (GeneRIF, showing 1)
- We suggest that the entanglements between the mosaic disorder-ordered segments in NBPF15 N terminus have triggered the multiple types of aggregates and phase transition of NBPF15 proteins, which could be associated with Olduvai-related cognitive dysfunction diseases (PMID:31808794)
Cross-species orthologs
0 orthologs
Paralogs (14): NBPF3 (ENSG00000142794), NBPF20 (ENSG00000162825), NBPF6 (ENSG00000186086), NBPF4 (ENSG00000196427), NBPF1 (ENSG00000219481), NBPF11 (ENSG00000263956), NBPF12 (ENSG00000268043), NBPF9 (ENSG00000269713), NBPF8 (ENSG00000270231), NBPF14 (ENSG00000270629), (ENSG00000271254), NBPF19 (ENSG00000271383), NBPF10 (ENSG00000271425), NBPF26 (ENSG00000273136)
Protein
Protein identifiers
NBPF family member NBPF15 — Q8N660 (reviewed: Q8N660)
Alternative names: Neuroblastoma breakpoint family member 15, Neuroblastoma breakpoint family member 16
All UniProt accessions (3): Q8N660, A0A087WVG8, A0A8I5KV21
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Cytoplasm.
Tissue specificity. Ubiquitously expressed with a higher expression observed in breast and liver. Also expressed in neuroblastoma cell line.
Miscellaneous. Encoded by one of the numerous copies of NBPF genes clustered in the p36, p12 and q21 region of the chromosome 1.
Similarity. Belongs to the NBPF family.
RefSeq proteins (54): NP_001164226, NP_001372302, NP_001372303, NP_001372304, NP_001372305, NP_001372306, NP_001372307, NP_001372332, NP_001372333, NP_001372334, NP_001372335, NP_001372336, NP_001372337, NP_001372338, NP_001372339, NP_001372340, NP_001372341, NP_001372342, NP_001372343, NP_001372344, NP_001372345, NP_001372346, NP_001372347, NP_001372348, NP_001372349, NP_001372350, NP_001372351, NP_001372352, NP_001372353, NP_001372354, NP_001372355, NP_001372356, NP_001372357, NP_001372358, NP_001372359, NP_001372360, NP_001372361, NP_001372362, NP_001372363, NP_001372364, NP_001372365, NP_001372366, NP_001372367, NP_001372368, NP_001372369, NP_001372370, NP_001372371, NP_001372372, NP_001372373, NP_001372374, NP_001372375, NP_001372376, NP_001372377, NP_775909 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR010630 | Olduvai_dom | Domain |
| IPR055306 | NBPF | Family |
Pfam: PF06758
UniProt features (19 total): domain 6, sequence conflict 4, compositionally biased region 3, region of interest 3, chain 1, coiled-coil region 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8N660-F1 | 46.94 | 0.12 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 34 (showing top):
ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_DN, chr1q21, ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP, PECE_MAMMARY_STEM_CELL_DN, DACH1_TARGET_GENES, SKIL_TARGET_GENES, ZFP91_TARGET_GENES, MIR3529_3P, MIR33A_3P, MIR141_3P, MIR200A_3P, MIR5093, MIR580_3P, MIR4692, MIR4514
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (1): cytoplasm (GO:0005737)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| intracellular anatomical structure | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
510 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| NBPF15 | NOTCH2NLB | P0DPK3 | 540 |
| NBPF15 | FAM72B | Q86X60 | 461 |
| NBPF15 | PPIAL4D | F5H284 | 449 |
| NBPF15 | USP17L11 | C9JVI0 | 447 |
| NBPF15 | GOLGA8CP | A6NN73 | 447 |
| NBPF15 | SPDYE5 | A6NIY4 | 418 |
| NBPF15 | OR4F17 | Q8NGA8 | 417 |
| NBPF15 | PRAMEF15 | P0DUQ1 | 399 |
| NBPF15 | PPIAL4E | A0A075B759 | 378 |
| NBPF15 | FAM72C | H0Y354 | 368 |
| NBPF15 | SRGAP2B | P0DMP2 | 350 |
| NBPF15 | OR4M2 | Q8NGB6 | 348 |
| NBPF15 | PPIAL4A | Q9Y536 | 324 |
| NBPF15 | FAM72D | Q6L9T8 | 322 |
| NBPF15 | ZNF492 | Q9P255 | 322 |
IntAct
7 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| NBPF15 | F2RL1 | psi-mi:“MI:0915”(physical association) | 0.370 |
| NBPF15 | FXR1 | psi-mi:“MI:0915”(physical association) | 0.370 |
| NBPF15 | PACS2 | psi-mi:“MI:0915”(physical association) | 0.370 |
| NEK4 | E2F8 | psi-mi:“MI:0914”(association) | 0.350 |
| FMR1 | NBPF15 | psi-mi:“MI:0915”(physical association) | 0.000 |
| leuD | NBPF15 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (10): NBPF15 (Affinity Capture-MS), NBPF15 (Two-hybrid), NBPF15 (Proximity Label-MS), NBPF15 (Phenotypic Suppression), NBPF15 (Two-hybrid), NBPF15 (Negative Genetic), NBPF15 (Negative Genetic), NBPF15 (Negative Genetic), NBPF15 (Affinity Capture-RNA), KDM1A (Two-hybrid)
ESM2 similar proteins: A0A087WUL8, A0A0J9YWL9, A0A0J9YY54, A0A0U1RQI7, A6NJ88, A6QL64, B4DH59, D3ZVV1, E9Q6E9, F1LWT0, O04492, O88799, P0DKJ7, P0DKJ8, P0DKL2, P0DPF3, P18583, P53353, Q08AG5, Q0P6D6, Q2EG98, Q3BBV2, Q4ZJZ1, Q5HY64, Q5JPF3, Q5QGU6, Q5TAG4, Q5TI25, Q5XHX6, Q6P3W6, Q6P902, Q6XPR3, Q6ZQX7, Q86T75, Q86VE3, Q86VQ3, Q8N2N9, Q8N660, Q8N693, Q96EQ9
Diamond homologs: A0A087WUL8, B4DH59, P0C2Y1, P0DPF2, P0DPF3, Q32LC2, Q3BBV0, Q3BBV2, Q5TAG4, Q5TI25, Q5VU43, Q5VWK0, Q6P3W6, Q86T75, Q86XG9, Q8N660, Q96M43, Q9H094, A0A096LNW5, A2RUV0, G3I6Z6, O35516, P0DPK3, P0DPK4, P10040, P21783, P46530, P46531, Q01705, Q04721, Q04756, Q07008, Q20911, Q7Z3S9, Q80YT7, Q99466, Q9QW30, Q9UM47, Q19UN5, Q8K389
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
154 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 1 |
| Likely pathogenic | 0 |
| Uncertain significance | 128 |
| Likely benign | 17 |
| Benign | 3 |
Top pathogenic / likely-pathogenic (1)
| Variant ID | HGVS | Classification |
|---|---|---|
| 4682496 | GRCh37/hg19 1q21.1-21.2(chr1:146125775-148884815)x1 | Pathogenic |
SpliceAI
2184 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:144423866:T:G | donor_loss | 1.0000 |
| 1:144423869:AGGTA:A | donor_loss | 1.0000 |
| 1:144423871:CCAGG:C | donor_loss | 1.0000 |
| 1:144423872:CCCAG:C | donor_loss | 1.0000 |
| 1:144424685:CTCA:C | donor_loss | 1.0000 |
| 1:144424686:TCACC:T | donor_loss | 1.0000 |
| 1:144424687:CACCT:C | donor_loss | 1.0000 |
| 1:144424688:A:AC | donor_gain | 1.0000 |
| 1:144424688:A:T | donor_loss | 1.0000 |
| 1:144424688:ACCT:A | donor_gain | 1.0000 |
| 1:144424688:ACCTC:A | donor_gain | 1.0000 |
| 1:144424689:C:CT | donor_gain | 1.0000 |
| 1:144424689:CCT:C | donor_gain | 1.0000 |
| 1:144424689:CCTC:C | donor_gain | 1.0000 |
| 1:144424689:CCTCC:C | donor_gain | 1.0000 |
| 1:144426276:A:AC | donor_gain | 1.0000 |
| 1:144426276:ACTGT:A | donor_gain | 1.0000 |
| 1:144426277:C:CA | donor_gain | 1.0000 |
| 1:144426277:CTGT:C | donor_gain | 1.0000 |
| 1:144426277:CTGTC:C | donor_gain | 1.0000 |
| 1:144426450:CCTGG:C | acceptor_loss | 1.0000 |
| 1:144426451:C:CA | acceptor_loss | 1.0000 |
| 1:144426451:C:CC | acceptor_gain | 1.0000 |
| 1:144437941:T:G | donor_loss | 1.0000 |
| 1:144437941:TCA:T | donor_loss | 1.0000 |
| 1:144437942:G:A | donor_loss | 1.0000 |
| 1:144437943:A:AG | donor_loss | 1.0000 |
| 1:144437943:GG:G | donor_loss | 1.0000 |
| 1:144437944:AGGT:A | donor_loss | 1.0000 |
| 1:144437945:CAG:C | donor_loss | 1.0000 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1043751 (1:144423198 T>A,C), RS1058107 (1:144443041 T>C,G), RS1058121 (1:144442773 A>G), RS1058122 (1:144442757 A>C,G), RS1058126 (1:144442587 C>A,T), RS1065451 (1:144440948 A>G), RS111234729 (1:144453143 T>A), RS111338061 (1:144462367 A>C), RS111389537 (1:144459618 A>G), RS111406432 (1:144422050 A>AAC), RS111507951 (1:144423797 A>G), RS111615504 (1:144460784 T>TAGAC), RS111628885 (1:144428106 T>G), RS111661293 (1:144423837 C>G), RS111689283 (1:144446953 C>T)
Disease associations
OMIM: gene MIM:610414 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
9 total (human), top 9 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| GSK-J4 | increases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| ethyl-p-hydroxybenzoate | increases expression | 1 |
| tris(2-butoxyethyl) phosphate | affects expression | 1 |
| Resveratrol | affects cotreatment, increases expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Pesticides | decreases expression | 1 |
| Plant Extracts | increases expression, affects cotreatment | 1 |
| Cadmium Chloride | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.